Literature DB >> 19632319

FcepsilonRI-mediated mast cell migration: signaling pathways and dependence on cytosolic free Ca2+ concentration.

In Duk Jung1, Hyun-Sil Lee, Hoi Young Lee, Oksoon Hong Choi.   

Abstract

IgE-sensitized rat basophilic leukemia (RBL)-2H3 mast cells have been shown to migrate towards antigen. In the present study we tried to identify the mechanism by which antigen causes mast cell migration. Antigen caused migration of RBL-2H3 cells at the concentration ranges of 1000-fold lower than those required for degranulation and the dose response was biphasic. This suggests that mast cells can detect very low concentration gradients of antigen (pg/ml ranges), which initiate migration until they degranulate near the origin of antigen, of which concentration is in the ng/ml ranges. Similar phenomenon was observed in human mast cells (HMCs) derived from CD34(+) progenitors. As one mechanism of mast cell migration, we tested the involvement of sphingosine 1-phosphate (S1P). Fc epsilon RI-mediated cell migration was dependent on the production of S1P but independent of a S1P receptor or its signaling pathways as determined with S1P receptor antagonist VPC23019 and Gi protein inhibitor pertussis toxin (PTX). This indicated that the site of action of S1P produced by antigen stimulation was intracellular. However, S1P-induced mast cell migration was dependent on S1P receptor activation and inhibited by both VPC23019 and PTX. Cell migration towards antigen or extracellular S1P was dependent on the activation of the phosphatidylinositol 3-kinase (PI3K) and mitogen-activated protein kinase (MAPK) pathways, while only migration towards antigen was inhibited by the inhibitors of sphingosine kinase and phospholipase C (PLC) and intracellular calcium chelator BAPTA. In summary, our data suggest that the high affinity receptor for IgE (Fc epsilon RI)-mediated mast cell migration is dependent on the production of S1P but independent of S1P receptors. Cell migration mediated by either Fc epsilon RI or S1P receptors involves activation of both PI3K and MAPK.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19632319      PMCID: PMC2752894          DOI: 10.1016/j.cellsig.2009.07.008

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  44 in total

Review 1.  Signalling through the high-affinity IgE receptor Fc epsilonRI.

Authors:  H Turner; J P Kinet
Journal:  Nature       Date:  1999-11-25       Impact factor: 49.962

Review 2.  Roles of mast cells and basophils in innate and acquired immunity.

Authors:  J Wedemeyer; M Tsai; S J Galli
Journal:  Curr Opin Immunol       Date:  2000-12       Impact factor: 7.486

3.  Immunohistochemical study of the presence of mast cells in idiopathic orbital inflammatory pseudotumor: possible role of mast cells in the course of its pathogenesis.

Authors:  Jianhua Yan; Yongping Li; Haijiang Qiu; Guilan Lu; Zhongyao Wu; Jianxian Lin; Wenxin Zhang
Journal:  Int Ophthalmol       Date:  2007-04-12       Impact factor: 2.031

4.  Cross-linking of FcepsilonRI causes Ca2+ mobilization via a sphingosine kinase pathway in a clathrin-dependent manner.

Authors:  Seung-Duk Ryu; Hyun Sil Lee; Ho Young Suk; Chang-Shin Park; Oksoon Hong Choi
Journal:  Cell Calcium       Date:  2009-02       Impact factor: 6.817

Review 5.  Lysophospholipids--receptor revelations.

Authors:  T Hla; M J Lee; N Ancellin; J H Paik; M J Kluk
Journal:  Science       Date:  2001-11-30       Impact factor: 47.728

6.  Mast cell distribution and activation in chronic pancreatitis.

Authors:  I Esposito; H Friess; A Kappeler; S Shrikhande; J Kleeff; H Ramesh; A Zimmermann; M W Büchler
Journal:  Hum Pathol       Date:  2001-11       Impact factor: 3.466

Review 7.  Mast cell lineage development and phenotypic regulation.

Authors:  K F Austen; J A Boyce
Journal:  Leuk Res       Date:  2001-07       Impact factor: 3.156

8.  Sensitized mast cells migrate toward the antigen: a response regulated by p38 mitogen-activated protein kinase and Rho-associated coiled-coil-forming protein kinase.

Authors:  T Ishizuka; F Okajima; M Ishiwara; K Iizuka; I Ichimonji; T Kawata; H Tsukagoshi; K Dobashi; T Nakazawa; M Mori
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

9.  Involvement of mast cells in gastritis caused by Helicobacter pylori: a potential role in epithelial cell apoptosis.

Authors:  Véronique Hofman; Sandra Lassalle; Eric Selva; Kheira Kalem; Adrien Steff; Xavier Hébuterne; Dominique Sicard; Patrick Auberger; Paul Hofman
Journal:  J Clin Pathol       Date:  2007-06       Impact factor: 3.411

10.  The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis.

Authors:  Ana Olivera; Kiyomi Mizugishi; Anastassia Tikhonova; Laura Ciaccia; Sandra Odom; Richard L Proia; Juan Rivera
Journal:  Immunity       Date:  2007-03-08       Impact factor: 31.745

View more
  12 in total

1.  Macelignan inhibits histamine release and inflammatory mediator production in activated rat basophilic leukemia mast cells.

Authors:  Young Sun Han; Myung-Suk Kim; Jae-Kwan Hwang
Journal:  Inflammation       Date:  2012-10       Impact factor: 4.092

2.  Critical role for the catalytic activity of phospholipase C-gamma1 in epidermal growth factor-induced cell migration.

Authors:  Zhongjian Xie; Jian Peng; Sally D Pennypacker; Ying Chen
Journal:  Biochem Biophys Res Commun       Date:  2010-07-30       Impact factor: 3.575

3.  Molecular mechanisms of spontaneous and directed mast cell motility.

Authors:  Jinmin Lee; Sarah L Veatch; Barbara Baird; David Holowka
Journal:  J Leukoc Biol       Date:  2012-08-02       Impact factor: 4.962

4.  Transcription factor NF-κB regulates expression of pore-forming Ca2+ channel unit, Orai1, and its activator, STIM1, to control Ca2+ entry and affect cellular functions.

Authors:  Anja Eylenstein; Sebastian Schmidt; Shuchen Gu; Wenting Yang; Evi Schmid; Eva-Maria Schmidt; Ioana Alesutan; Kalina Szteyn; Ivonne Regel; Ekaterina Shumilina; Florian Lang
Journal:  J Biol Chem       Date:  2011-11-21       Impact factor: 5.157

5.  Btk-dependent Rac activation and actin rearrangement following FcepsilonRI aggregation promotes enhanced chemotactic responses of mast cells.

Authors:  Hye Sun Kuehn; Madeleine Rådinger; Jared M Brown; Khaled Ali; Bart Vanhaesebroeck; Michael A Beaven; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  J Cell Sci       Date:  2010-06-29       Impact factor: 5.285

6.  Catestatin, a neuroendocrine antimicrobial peptide, induces human mast cell migration, degranulation and production of cytokines and chemokines.

Authors:  Gyi Aung; François Niyonsaba; Hiroko Ushio; Naoki Kajiwara; Hirohisa Saito; Shigaku Ikeda; Hideoki Ogawa; Ko Okumura
Journal:  Immunology       Date:  2011-01-07       Impact factor: 7.397

7.  Mammalian diaphanous-related formin 1 (mDia1) coordinates mast cell migration and secretion through its actin-nucleating activity.

Authors:  Ofir Klein; Rebecca A Krier-Burris; Pia Lazki-Hagenbach; Yaara Gorzalczany; Yang Mei; Peng Ji; Bruce S Bochner; Ronit Sagi-Eisenberg
Journal:  J Allergy Clin Immunol       Date:  2019-07-03       Impact factor: 10.793

8.  Dexamethasone rapidly suppresses IL-33-stimulated mast cell function by blocking transcription factor activity.

Authors:  Anuya Paranjape; Oksana Chernushevich; Amina Abdul Qayum; Andrew J Spence; Marcela T Taruselli; Daniel Abebayehu; Brian O Barnstein; Jamie Josephine Avila McLeod; Bianca Baker; Gurjas S Bajaj; Alena P Chumanevich; Carole A Oskeritzian; John J Ryan
Journal:  J Leukoc Biol       Date:  2016-07-21       Impact factor: 4.962

9.  Cooperative Interactions of Oligosaccharide and Peptide Moieties of a Glycopeptide Derived from IgE with Galectin-9.

Authors:  Shin-Ichi Nakakita; Aiko Itoh; Yukari Nakakita; Yasuhiro Nonaka; Takashi Ogawa; Takanori Nakamura; Nozomu Nishi
Journal:  J Biol Chem       Date:  2015-11-18       Impact factor: 5.157

10.  Mesenteric lymph node transcriptome profiles in BALB/c mice sensitized to three common food allergens.

Authors:  Mainul Husain; Herman J Boermans; Niel A Karrow
Journal:  BMC Genomics       Date:  2011-01-06       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.